Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency-Reference-Cited by-同舟云学术

Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency

Published:2017-07-17 Issue:8 Volume:127 Page:3126-3135
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Archin Nancie M.,Kirchherr Jennifer L.,Sung Julia A.M.,Clutton Genevieve,Sholtis Katherine,Xu Yinyan,Allard Brigitte,Stuelke Erin,Kashuba Angela D.,Kuruc Joann D.,Eron Joseph^ORCID,Gay Cynthia L.,Goonetilleke Nilu,Margolis David M.^ORCID

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/92684/files/pdf

Reference39 articles.

1. Histone deacetylases and cancer

2. A Limited Group of Class I Histone Deacetylases Acts To Repress Human Immunodeficiency Virus Type 1 Expression

3. Shocking HIV out of hiding

4. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

5. Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy;Elliott;PLoS Pathog,2014

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the effect of HDAC inhibitors on the formation of the HIV reservoir;mBio;2024-09-11

2. Development of a latency model based on HIV-1 subtype C to study how long terminal repeat genetic variation impacts viral persistence and latency reversal;2024-08-02

3. Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques;2024-05-09

4. Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques;2024-05-09

5. Differential susceptibility of cells infected with defective and intact HIV proviruses to killing by obatoclax and other small molecules;AIDS;2024-04-20